News

January 15, 2021

Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units (Canadian Version)

No event, press release or news were announced this month yet. You can stay up to date by subscribing to our alerts or by subscribing to our RSS feed.

News

Configure my alerts RSS feed

Date

Title and excerpt

January 15, 2021

Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units (Canadian Version)

January 15, 2021

Theratechnologies To Present At The B. Riley Securities Virtual Oncology Investor Conference

January 11, 2021

Theratechnologies Announces US$40 Million Bought-Deal Public Offering Of Units

January 07, 2021

Theratechnologies Announces Preliminary Fourth Quarter And Full Fiscal Year 2020 Revenues And Provides Update On R&D Activities

December 08, 2020

Theratechnologies Announces New Findings For Its Lead Investigational Compound TH1902 For The Treatment Of Several Additional Cancers

November 23, 2020

Theratechnologies To Present At The Piper Sandler Virtual Healthcare Conference

November 23, 2020

Fireside Chat – Piper Sandler Virtual Healthcare Conference

November 16, 2020

Theratechnologies Announces Data From Oral Presentation At AASLD Showing How Tesamorelin Can Reduce Fibrosis And NASH

November 09, 2020

Theratechnologies’ Presentation at the Credit Suisse Virtual Healthcare Conference

November 06, 2020

Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020

1 2 3 4 ... 28 29 >

Configure my alerts RSS feed